Total Payments
$1,740
2021 Payments
$479.54
Companies
15
Transactions
78
Medicare Patients
465
Medicare Billing
$103,171
Payment Breakdown by Category
Food & Beverage$1,695 (97.4%)
Education$45.70 (2.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,695 | 76 | 97.4% |
| Education | $45.70 | 2 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $335.76 | 19 | $0 (2021) |
| CIPLA USA INC. | $295.50 | 1 | $0 (2021) |
| Allergan, Inc. | $292.36 | 11 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $142.20 | 10 | $0 (2019) |
| Gilead Sciences Inc | $112.22 | 8 | $0 (2017) |
| Melinta Therapeutics, Inc. | $111.12 | 5 | $0 (2018) |
| Theravance Biopharma, Inc. | $104.50 | 5 | $0 (2018) |
| Insmed, Inc. | $95.59 | 5 | $0 (2021) |
| Astellas Pharma US Inc | $64.34 | 4 | $0 (2018) |
| TETRAPHASE PHARMACEUTICALS, INC. | $55.36 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $479.54 | 4 | CIPLA USA INC. ($295.50) |
| 2020 | $176.74 | 9 | ViiV Healthcare Company ($52.30) |
| 2019 | $281.36 | 17 | ViiV Healthcare Company ($85.66) |
| 2018 | $406.15 | 22 | Melinta Therapeutics, Inc. ($111.12) |
| 2017 | $396.48 | 26 | Gilead Sciences Inc ($112.22) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2021 | Allergan, Inc. | NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) | Food and Beverage | In-kind items and services | $148.85 | General |
| Category: PLASTICS | ||||||
| 03/23/2021 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: HIV | ||||||
| 03/01/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: Respiratory | ||||||
| 01/14/2021 | CIPLA USA INC. | ZEMDRI (PLAZOMICIN) (Drug) | Food and Beverage | Cash or cash equivalent | $295.50 | General |
| Category: ANTIBIOTICS | ||||||
| 12/08/2020 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Respiratory | ||||||
| 10/16/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: HIV | ||||||
| 09/25/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: HIV | ||||||
| 08/24/2020 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Education | In-kind items and services | $33.00 | General |
| Category: ANTIBIOTIC | ||||||
| 06/27/2020 | Allergan, Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/20/2020 | TETRAPHASE PHARMACEUTICALS, INC. | XERAVA (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 02/07/2020 | Nabriva Therapeutics, plc | Xenleta (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Antibiotic | ||||||
| 02/05/2020 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Respiratory | ||||||
| 01/06/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: HIV | ||||||
| 12/24/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: HIV | ||||||
| 12/18/2019 | TETRAPHASE PHARMACEUTICALS, INC. | Xerava (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Complicated Intra-Abdominal Infections | ||||||
| 12/09/2019 | TETRAPHASE PHARMACEUTICALS, INC. | Xerava (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Complicated Intra-Abdominal Infections | ||||||
| 12/05/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: HIV | ||||||
| 11/08/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Education | In-kind items and services | $12.70 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/03/2019 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), PIFELTRO, DIFICID | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/22/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/31/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: HIV | ||||||
| 07/22/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/08/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: HIV | ||||||
| 06/12/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Respiratory | ||||||
| 06/03/2019 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), PIFELTRO, DIFICID | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 8 | 465 | 1,251 | $205,380 | $103,171 |
Total Patients
465
Total Services
1,251
Medicare Billing
$103,171
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 125 | 361 | $36,100 | $23,082 | 63.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 65 | 213 | $28,755 | $19,734 | 68.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 73 | 201 | $30,150 | $17,685 | 58.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 14 | 279 | $62,775 | $16,981 | 27.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 76 | 81 | $24,300 | $14,543 | 59.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 74 | 78 | $21,450 | $9,693 | 45.2% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 18 | 18 | $1,350 | $1,098 | 81.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 20 | 20 | $500.00 | $355.84 | 71.2% |
About Dr. Richard Levine, M.D
Dr. Richard Levine, M.D is a Infectious Disease healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1497758502.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Levine, M.D has received a total of $1,740 in payments from pharmaceutical and medical device companies, with $479.54 received in 2021. These payments were reported across 78 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,695).
As a Medicare-enrolled provider, Levine has provided services to 465 Medicare beneficiaries, totaling 1,251 services with total Medicare billing of $103,171. Data is available for 1 year (2020–2020), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Miami, FL
- Active Since 05/23/2005
- Last Updated 10/04/2007
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1497758502
Products in Payments
- ZEMDRI (PLAZOMICIN) (Drug) $295.50
- DOVATO (Drug) $161.02
- NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) $148.85
- TRIUMEQ (Drug) $128.07
- Baxdela (Drug) $111.12
- VIBATIV (Drug) $104.50
- Arikayce (Drug) $95.59
- DALVANCE (Drug) $91.01
- AVYCAZ (Drug) $52.50
- PREZCOBIX (Drug) $50.76
- JULUCA (Drug) $46.67
- ZERBAXA (Drug) $44.59
- ISENTRESS (Drug) $39.29
- Xerava (Drug) $35.61
- NUZYRA (Drug) $33.00
- Cresemba (Drug) $32.49
- CRESEMBA (Drug) $31.85
- CUBICIN RF (Drug) $29.77
- XERAVA (Drug) $19.75
- PREVNAR - 13 (Biological) $16.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Miami
Douglas Brust, M.d, M.D
Infectious Disease — Payments: $450,213
Infectious Disease $450,213
Ricardo Fonseca Franco
Infectious Disease — Payments: $135,298
Infectious Disease $135,298
Hector Bolivar, Md, MD
Infectious Disease — Payments: $105,997
Infectious Disease $105,997
Jorge Murillo, Md, MD
Infectious Disease — Payments: $85,760
Infectious Disease $85,760
Dushyantha Jayaweera, Md, MD
Infectious Disease — Payments: $79,219
Infectious Disease $79,219
Dr. Lilian Abbo, Md, MD
Infectious Disease — Payments: $69,205
Infectious Disease $69,205